RND - ETF AI Analysis
Top Page
First Trust Bloomberg R&D Leaders ETF (RND)
RND, the First Trust Bloomberg R&D Leaders ETF, earns a solid overall rating thanks to its heavy exposure to innovative tech leaders like Microsoft and Alphabet, whose strong financial performance, growth in cloud and AI, and generally supportive technical trends provide a powerful foundation for the fund. Additional strength comes from major positions in Apple, Nvidia, and Broadcom, which benefit from robust profitability and strategic focus on AI and data centers, though their premium valuations and occasional technical or geopolitical risks can limit upside. The main risk factor is the fund’s concentration in high-valuation, R&D-heavy technology and semiconductor names, which could make it more sensitive to market pullbacks or shifts in sentiment toward growth stocks.
RND vs. SPDR S&P 500 ETF (SPY)
- AUM
- 9.87M
- Region
- North America
- Expense Ratio
- 0.60%
- Beta
- 1.26
- Issuer
- First Trust
- Inception Date
- Apr 30, 2024
- Dividend Yield
- 0.03%
- Asset Class
- Equity
- Index Tracked
- Bloomberg R&D Leaders Select TR
RND Summary
The First Trust Bloomberg R&D Leaders ETF (RND) follows the Bloomberg R&D Leaders Select index, focusing on companies that spend heavily on research and development to drive future innovation. It mainly holds large U.S. firms in technology and health care, including well-known names like Apple and Microsoft, along with other major tech and pharma leaders. Someone might invest in RND to gain diversified exposure to innovative companies that could benefit from long-term growth driven by new products and technologies. A key risk is that it is heavily tilted toward tech and other growth stocks, so its price can rise and fall sharply with market swings and changes in investor sentiment.
How much will it cost me?
This ETF has an expense ratio of 0.60%, which means you’ll pay about $6 per year for every $1,000 you invest. That’s higher than the average cost for broad, passively managed index ETFs because this fund follows a more specialized strategy focused on R&D leaders, which typically requires more active research and management.
What would affect this ETF?
RND is heavily invested in innovative U.S. technology and health care companies like Amazon, Microsoft, Apple, and Nvidia, so it could benefit if demand for new digital tools, artificial intelligence, and medical breakthroughs stays strong and the U.S. economy remains healthy. On the downside, the fund could be hurt by rising interest rates that pressure growth stocks, tighter regulations on big tech or drug makers, or an economic slowdown that reduces spending on research and development and consumer services.
RND Top 10 Holdings
RND is essentially an innovation engine powered by U.S. Big Tech and chipmakers. Nvidia and AMD have been the fund’s turbochargers, with their AI-focused businesses rising and giving performance a strong lift. Apple and Meta are also pulling their weight, staying firmly in the growth lane. On the other side, Amazon and Alphabet have been more mixed lately, occasionally tapping the brakes, while Broadcom has lost a bit of momentum. With heavy exposure to U.S. technology and health care, this ETF is a concentrated bet on R&D-driven disruption.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 MSFT | Microsoft | 8.36% | $834.19K | $3.95T | -2.04% | 79Outperform |
 AAPL | Apple | 8.40% | $838.94K | $5.07T | 27.82% | 79Outperform |
 AMZN | Amazon | 8.19% | $817.77K | $2.73T | 11.06% | 71Outperform |
 NVDA | Nvidia | 7.69% | $768.24K | $5.25T | 7.14% | 76Outperform |
 GOOGL | Alphabet Class A | 7.51% | $750.16K | $3.90T | 21.47% | 85Outperform |
 LLY | Eli Lilly & Co | 4.47% | $446.10K | $1.21T | 57.09% | 72Outperform |
 TSLA | Tesla | 4.63% | $462.06K | $1.61T | -12.23% | 73Outperform |
 AVGO | Broadcom | 3.93% | $392.31K | $1.63T | -5.67% | 76Outperform |
 META | Meta Platforms | 3.45% | $344.21K | $1.59T | -18.49% | 76Outperform |
 AMD | Advanced Micro Devices | 3.69% | $368.65K | $914.61B | 124.19% | 73Outperform |
RND Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RND, the sentiment is Positive. The current price of 33.43 is below the 20-day moving average (MA) of 33.60, above the 50-day MA of 33.25, and above the 200-day MA of 31.19, indicating a neutral trend. The MACD of -0.07 indicates Positive momentum. The RSI at 50.84 is Neutral, neither overbought nor oversold. The STOCH value of 53.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RND.
RND Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| RND | $33.43 | $38.00(13.66% Upside) | $9.87M | 0.60% | 76Outperform |
 BAMD | $34.36 | $37.91(10.34% Upside) | $100.25M | 0.87% | 70Outperform |
 STNC | $36.86 | $42.50(15.29% Upside) | $92.52M | 0.85% | 68Neutral |
 SOVF | $31.89 | $37.51(17.61% Upside) | $91.03M | 0.75% | 70Neutral |
 BUZZ | $35.99 | $50.76(41.04% Upside) | $89.93M | 0.76% | 65Neutral |
 PFOE | $22.21 | $28.85(29.87% Upside) | $88.08M | 0.59% | 75Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| RND | First Trust Bloomberg R&D Leaders ETF | 33.43 | 2.69 | 8.75% | |
| BAMD | Brookstone Dividend Stock ETF | 34.36 | 5.46 | 18.89% | |
| STNC | Stance Equity ESG Large Cap Core ETF | 36.86 | 4.35 | 13.39% | |
| SOVF | Sovereign's Capital Flourish Fund | 31.89 | 3.25 | 11.37% | |
| BUZZ | VanEck Social Sentiment ETF | 35.99 | -1.25 | -3.36% | |
| PFOE | Pathfinder Focused Opportunities ETF | 22.21 | -2.64 | -10.64% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.